Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data

Preoperative or postoperative radiation therapy is broadly employed in patients with rectal carcinoma. Radiotherapy directs high-energy beams of ionizing radiation toward the tumor area to destroy cancer cells. High radiation doses are needed for cell killing. The radiation exposure of the healthy t...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefanos Kachris, Michalis Mazonakis
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/14/24/12063
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850041785639763968
author Stefanos Kachris
Michalis Mazonakis
author_facet Stefanos Kachris
Michalis Mazonakis
author_sort Stefanos Kachris
collection DOAJ
description Preoperative or postoperative radiation therapy is broadly employed in patients with rectal carcinoma. Radiotherapy directs high-energy beams of ionizing radiation toward the tumor area to destroy cancer cells. High radiation doses are needed for cell killing. The radiation exposure of the healthy tissues/organs may lead to carcinogenesis. This study describes the evolving role of radiotherapy in rectal cancer management. The present report also reviews epidemiological and dosimetric studies related to the radiation-induced second malignancies from pelvic radiotherapy. Some epidemiological studies have concluded that the second-cancer risk in patients subjected to radiation therapy does not increase compared to unexposed rectal cancer patients. Other researchers found an elevated or a marginally increased probability for second-cancer induction. Dosimetric studies reported cancer risk estimates for critical organs or tissues in the near and far periphery of the treatment volume. Useful information about the effect of the treatment parameters such as the irradiation technique, photon beam energy, and fractionation schedule on the organ-specific second-cancer risk was derived from the dose data analysis. The knowledge of these effects is needed for the selection of the optimal treatment parameters enabling a reduction in the resultant risk of carcinogenesis.
format Article
id doaj-art-b991fb0284604b7082c96b88f791fda0
institution DOAJ
issn 2076-3417
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj-art-b991fb0284604b7082c96b88f791fda02025-08-20T02:55:42ZengMDPI AGApplied Sciences2076-34172024-12-0114241206310.3390/app142412063Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric DataStefanos Kachris0Michalis Mazonakis1Department of Radiation Oncology, University Hospital of Iraklion, 71110 Iraklion, GreeceDepartment of Medical Physics, Faculty of Medicine, University of Crete, 71003 Iraklion, GreecePreoperative or postoperative radiation therapy is broadly employed in patients with rectal carcinoma. Radiotherapy directs high-energy beams of ionizing radiation toward the tumor area to destroy cancer cells. High radiation doses are needed for cell killing. The radiation exposure of the healthy tissues/organs may lead to carcinogenesis. This study describes the evolving role of radiotherapy in rectal cancer management. The present report also reviews epidemiological and dosimetric studies related to the radiation-induced second malignancies from pelvic radiotherapy. Some epidemiological studies have concluded that the second-cancer risk in patients subjected to radiation therapy does not increase compared to unexposed rectal cancer patients. Other researchers found an elevated or a marginally increased probability for second-cancer induction. Dosimetric studies reported cancer risk estimates for critical organs or tissues in the near and far periphery of the treatment volume. Useful information about the effect of the treatment parameters such as the irradiation technique, photon beam energy, and fractionation schedule on the organ-specific second-cancer risk was derived from the dose data analysis. The knowledge of these effects is needed for the selection of the optimal treatment parameters enabling a reduction in the resultant risk of carcinogenesis.https://www.mdpi.com/2076-3417/14/24/12063rectal cancerradiotherapysecond malignanciesepidemiological datadosimetry
spellingShingle Stefanos Kachris
Michalis Mazonakis
Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
Applied Sciences
rectal cancer
radiotherapy
second malignancies
epidemiological data
dosimetry
title Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
title_full Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
title_fullStr Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
title_full_unstemmed Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
title_short Radiotherapy for Rectal Cancer and Radiation-Induced Malignancies from Epidemiological and Dosimetric Data
title_sort radiotherapy for rectal cancer and radiation induced malignancies from epidemiological and dosimetric data
topic rectal cancer
radiotherapy
second malignancies
epidemiological data
dosimetry
url https://www.mdpi.com/2076-3417/14/24/12063
work_keys_str_mv AT stefanoskachris radiotherapyforrectalcancerandradiationinducedmalignanciesfromepidemiologicalanddosimetricdata
AT michalismazonakis radiotherapyforrectalcancerandradiationinducedmalignanciesfromepidemiologicalanddosimetricdata